Merck reported Q2 FY 2016 earnings of $0.93 per share (versus $0.86 in Q2 FY 2015), beating analysts’ consensus estimate of $0.91.
The company’s quarterly revenues amounted to $9.844 bln (+0.6% y/y), slightly beating analysts’ consensus estimate of $9.783 bln.
MRK closed Thursday’s trading session at $58.43 (-0.29%).
The post Company News: Merck (MRK) Q2 results beat analysts’ expectations appeared first on forex-analytics.press.